{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:12:49Z","timestamp":1783390369386,"version":"3.54.6"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MC_PC_15001"],"award-info":[{"award-number":["MC_PC_15001"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust of Great Britain","award":["107834\/Z\/15\/Z and106491\/Z\/14\/Z"],"award-info":[{"award-number":["107834\/Z\/15\/Z and106491\/Z\/14\/Z"]}]},{"name":"EU FP7 project PREPARE","award":["602525"],"award-info":[{"award-number":["602525"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1116588"],"award-info":[{"award-number":["OPP1116588"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Rhodes Trust","award":["Rhodes Scholarship"],"award-info":[{"award-number":["Rhodes Scholarship"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0760-x","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T16:38:49Z","timestamp":1481560729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Modernising epidemic science: enabling patient-centred research during epidemics"],"prefix":"10.1186","volume":"14","author":[{"given":"Amanda M.","family":"Rojek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Horby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"issue":"1","key":"760_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12916-016-0686-3","volume":"14","author":"A Zumla","year":"2016","unstructured":"Zumla A, Alagaili AN, Cotten M, Azhar EI. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). BMC Med. 2016;14(1):132. doi:\n                    10.1186\/s12916-016-0686-3\n                    \n                  .","journal-title":"BMC Med"},{"key":"760_CR2","unstructured":"Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec. 2016;91(11):133\u201343. PMID: 27766828."},{"key":"760_CR3","unstructured":"Commission on a Global Health Risk Framework for the Future. The neglected dimension of global health security: a framework to counter infectious disease crises. 2016. \n                    https:\/\/nam.edu\/wp-content\/uploads\/2016\/01\/Neglected-Dimension-of-Global-Security.pdf\n                    \n                  . Accessed 13 Nov 2016."},{"issue":"101","key":"760_CR4","doi-asserted-by":"publisher","first-page":"20140950","DOI":"10.1098\/rsif.2014.0950","volume":"11","author":"KF Smith","year":"2014","unstructured":"Smith KF, Goldberg M, Rosenthal S, Carlson L, Chen J, Chen C, Ramachandran S. Global rise in human infectious disease outbreaks. J R Soc Interface. 2014;11(101):20140950.","journal-title":"J R Soc Interface"},{"key":"760_CR5","volume-title":"Treatment of MERS-CoV: information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients","author":"Public Health England","year":"2015","unstructured":"Public Health England. Treatment of MERS-CoV: information for clinicians. Clinical decision-making support for treatment of MERS-CoV patients. 3rd ed. London: Public Health England; 2015.","edition":"3"},{"issue":"Suppl 2","key":"760_CR6","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1086\/520542","volume":"196","author":"DG Bausch","year":"2007","unstructured":"Bausch DG, Feldmann H, Geisbert TW, Bray M, Sprecher AG, Boumandouki P, Rollin PE, Roth C, Winnipeg Filovirus Clinical Working Group. Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. J Infect Dis. 2007;196 Suppl 2:S136\u201341. doi:\n                    10.1086\/520542\n                    \n                  .","journal-title":"J Infect Dis"},{"issue":"26","key":"760_CR7","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","volume":"364","author":"K Maitland","year":"2011","unstructured":"Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. New Eng J Med. 2011;364(26):2483\u201395. doi:\n                    10.1056\/NEJMoa1101549\n                    \n                  .","journal-title":"New Eng J Med"},{"issue":"5","key":"760_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","volume":"2","author":"SG Muthuri","year":"2014","unstructured":"Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Resp Med. 2014;2(5):395\u2013404. doi:\n                    10.1016\/s2213-2600(14)70041-4\n                    \n                  .","journal-title":"Lancet Resp Med"},{"issue":"9979","key":"760_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","volume":"385","author":"J Dobson","year":"2015","unstructured":"Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729\u201337. doi:\n                    10.1016\/S0140-6736(14)62449-1\n                    \n                  .","journal-title":"Lancet"},{"key":"760_CR10","doi-asserted-by":"publisher","first-page":"g2545","DOI":"10.1136\/bmj.g2545","volume":"348","author":"T Jefferson","year":"2014","unstructured":"Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348:g2545. doi:\n                    10.1136\/bmj.g2545\n                    \n                  .","journal-title":"BMJ"},{"issue":"8","key":"760_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1365-3156.2004.01281.x","volume":"9","author":"HN Leong","year":"2004","unstructured":"Leong HN, Ang B, Earnest A, Teoh C, Xu W, Leo YS. Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003. Trop Med Int Health. 2004;9(8):923\u20137. doi:\n                    10.1111\/j.1365-3156.2004.01281\n                    \n                  .","journal-title":"Trop Med Int Health"},{"issue":"9","key":"760_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030343","volume":"3","author":"LJ Stockman","year":"2006","unstructured":"Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3(9), e343. doi:\n                    10.1371\/journal.pmed.0030343\n                    \n                  .","journal-title":"PLoS Med"},{"key":"760_CR13","doi-asserted-by":"publisher","first-page":"d652","DOI":"10.1136\/bmj.d652","volume":"342","author":"R Watson","year":"2011","unstructured":"Watson R. MEPs criticise WHO over H1N1 pandemic advice. BMJ. 2011;342:d652. doi:\n                    10.1136\/bmj.d652\n                    \n                  .","journal-title":"BMJ"},{"issue":"17","key":"760_CR14","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1001\/jama.2009.1496","volume":"302","author":"A Kumar","year":"2009","unstructured":"Kumar A, Zarychanski R, Pinto R, Cook D, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, et al. Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302(17):1872\u20139.","journal-title":"JAMA"},{"issue":"17","key":"760_CR15","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2009.1536","volume":"302","author":"G Dom\u00ednguez-Cherit","year":"2009","unstructured":"Dom\u00ednguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880\u20137.","journal-title":"JAMA"},{"issue":"4","key":"760_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/aje\/kwv054","volume":"82","author":"JY Wong","year":"2015","unstructured":"Wong JY, Kelly H, Cheung CM, Shiu EY, Wu P, Ni MY, Ip DK, Cowling BJ. Hospitalization fatality risk of influenza A(H1N1)pdm09: a systematic review and meta-analysis. Am J Epidemiol. 2015;82(4):294\u2013301. doi:\n                    10.1093\/aje\/kwv054\n                    \n                  .","journal-title":"Am J Epidemiol"},{"issue":"2","key":"760_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJMc1413936","volume":"372","author":"C Dye","year":"2015","unstructured":"Dye C. Ebola virus disease in West Africa--the first 9 months. New Engl J Med. 2015;372(2):189. doi:\n                    10.1056\/NEJMc1413884\n                    \n                  .","journal-title":"New Engl J Med"},{"issue":"6","key":"760_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMc1414992","volume":"372","author":"J Agua-Agum","year":"2015","unstructured":"Agua-Agum J, Ariyarajah A, Aylward B, et al. West African Ebola epidemic after one year--slowing but not yet under control. New Engl J Med. 2015;372(6):584\u20137. doi:\n                    10.1056\/NEJMc1414992\n                    \n                  .","journal-title":"New Engl J Med"},{"key":"760_CR19","unstructured":"World Health Organization. Case defintion recommendations for Ebola or Marburg virus diseases, 2014. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/146397\/1\/WHO_EVD_CaseDef_14.1_eng.pdf?ua=1&ua=1\n                    \n                  . Accessed 13 Nov 2016."},{"key":"760_CR20","unstructured":"Centers for Disease Control and Prevention. Case definition for Ebola Virus Disease (EVD), 2014. \n                    http:\/\/www.cdc.gov\/vhf\/ebola\/healthcare-us\/evaluating-patients\/case-definition.html\n                    \n                  . Accessed 13 Nov 2016."},{"issue":"25","key":"760_CR21","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMoa1509773","volume":"373","author":"SE Mate","year":"2015","unstructured":"Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. New Engl J Med. 2015;373(25):2448\u201354. doi:\n                    10.1056\/NEJMoa1509773\n                    \n                  .","journal-title":"New Engl J Med"},{"issue":"5","key":"760_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.15585\/mmwr.mm6505e2","volume":"65","author":"T Oduyebo","year":"2016","unstructured":"Oduyebo T, Petersen EE, Rasmussen SA, et al. Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(5):122\u20137. doi:\n                    10.15585\/mmwr.mm6505e2\n                    \n                  .","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"760_CR23","unstructured":"World Health Organization. Ethics in epidemics, emergencies and disasters: research, surveillance and patient care. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/196326\/1\/9789241549349_eng.pdf\n                    \n                   2015. Accessed 13 Nov 2016."},{"issue":"9","key":"760_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/jamasurg.2014.940","volume":"149","author":"NR Langan","year":"2014","unstructured":"Langan NR, Eckert M, Martin MJ. Changing patterns of in-hospital deaths following implementation of damage control resuscitation practices in US forward military treatment facilities. JAMA Surg. 2014;149(9):904\u201312. doi:\n                    10.1001\/jamasurg.2014.940\n                    \n                  .","journal-title":"JAMA Surg"},{"issue":"5","key":"760_CR25","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1097\/TA.0b013e3181f6f72f","volume":"70","author":"GE Davies","year":"2011","unstructured":"Davies GE, Lockey DJ. Thirteen survivors of prehospital thoracotomy for penetrating trauma: a prehospital physician-performed resuscitation procedure that can yield good results. J Trauma. 2011;70(5):E75\u20138. doi:\n                    10.1097\/TA.0b013e3181f6f72f\n                    \n                  .","journal-title":"J Trauma"},{"issue":"21","key":"760_CR26","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1056\/NEJMoa060334","volume":"356","author":"IG Stiell","year":"2007","unstructured":"Stiell IG, Spaite DW, Field B, et al. Advanced life support for out-of-hospital respiratory distress. New Engl J Med. 2007;356(21):2156\u201364. doi:\n                    10.1056\/NEJMoa060334\n                    \n                  .","journal-title":"New Engl J Med"},{"issue":"4","key":"760_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001815","volume":"12","author":"BS Cooper","year":"2015","unstructured":"Cooper BS, Boni MF, Pan-Ngum W, Day NP, Horby PW, Olliaro P, Lang T, White NJ, White LJ, Whitehead J. Evaluating clinical trial designs for investigational treatments of ebola virus disease. PLoS Med. 2015;12(4), e1001815. doi:\n                    10.1371\/journal.pmed.1001815\n                    \n                  .","journal-title":"PLoS Med"},{"key":"760_CR28","doi-asserted-by":"publisher","first-page":"h3740","DOI":"10.1136\/bmj.h3740","volume":"351","author":"Ebola \u00e7a Suffit Ring Vaccination Trial Consortium","year":"2015","unstructured":"Ebola \u00e7a Suffit Ring Vaccination Trial Consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ. 2015;351:h3740. doi:\n                    10.1136\/bmj.h3740\n                    \n                  .","journal-title":"BMJ"},{"issue":"9","key":"760_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020243","volume":"2","author":"A Fischer","year":"2005","unstructured":"Fischer A, Borensztein P, Roussel C. The European Rare Diseases Therapeutic Initiative. PLoS Med. 2005;2(9), e243. doi:\n                    10.1371\/journal.pmed.0020243\n                    \n                  .","journal-title":"PLoS Med"},{"key":"760_CR30","unstructured":"World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. \n                    http:\/\/www.who.int\/csr\/sars\/country\/table2004_04_21\/en\/\n                    \n                  . Accessed 13 Nov 2016."},{"key":"760_CR31","unstructured":"World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003\u20132016, 2016. \n                    http:\/\/www.who.int\/influenza\/human_animal_interface\/EN_GIP_20160404cumulativenumberH5N1cases.pdf?ua=1\n                    \n                  . Accessed 13 Nov 2016."},{"key":"760_CR32","doi-asserted-by":"crossref","unstructured":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV), 2016. \n                    http:\/\/www.who.int\/emergencies\/mers-cov\/en\/\n                    \n                  . Accessed 13 Nov 2016.","DOI":"10.5742\/MEWFM.2015.92625"},{"issue":"5","key":"760_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1023\/A:1007525402861","volume":"15","author":"DM Fleming","year":"1999","unstructured":"Fleming DM, Zambon M, Bartelds AI, de Jong JC. The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. Eur J Epidemiol. 1999;15(5):467\u201373.","journal-title":"Eur J Epidemiol"},{"key":"760_CR34","unstructured":"World Health Organization. Emerging disease surveillance and response - Avian Influenza Weekly Update Number 551, 2016. \n                    http:\/\/www.wpro.who.int\/emerging_diseases\/AvianInfluenza\/en\/\n                    \n                  . Accessed 13 Nov 2016."},{"issue":"1","key":"760_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1473-3099(13)70327-X","volume":"14","author":"JW Dunning","year":"2014","unstructured":"Dunning JW, Merson L, Rohde GG, et al. Open source clinical science for emerging infections. Lancet Infect Dis. 2014;14(1):8\u20139. doi:\n                    10.1016\/s1473-3099(13)70327-x\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"760_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000231","volume":"7","author":"HF Wertheim","year":"2010","unstructured":"Wertheim HF, Puthavathana P, Nghiem NM, et al. Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med. 2010;7(4), e1000231. doi:\n                    10.1371\/journal.pmed.1000231\n                    \n                  .","journal-title":"PLoS Med"},{"issue":"7","key":"760_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1164\/rccm.201412-2272ED","volume":"191","author":"SS Carson","year":"2015","unstructured":"Carson SS, Fowler RA, Cobb JP, Arabi YM, Ingbar DH. Global participation in core data sets for emerging pathogens. Am J Respir Crit Care Med. 2015;191(7):728\u201330. doi:\n                    10.1164\/rccm.201412-2272ED\n                    \n                  .","journal-title":"Am J Respir Crit Care Med"},{"key":"760_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s40064-015-1490-9","volume":"4","author":"Y Arabi","year":"2015","unstructured":"Arabi Y, Balkhy H, Hajeer AH, et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015;4:709. doi:\n                    10.1186\/s40064-015-1490-9\n                    \n                  .","journal-title":"Springerplus"},{"key":"760_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1186\/s13063-015-1110-6","volume":"16","author":"NH Gobat","year":"2015","unstructured":"Gobat NH, Gal M, Francis NA, Hood K, Watkins A, Turner J, Moore R, Webb SA, Butler CC, Nichol A. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi\/pandemic research preparedness. Trials. 2015;16:591. doi:\n                    10.1186\/s13063-015-1110-6\n                    \n                  .","journal-title":"Trials"},{"issue":"9","key":"760_CR40","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3201\/eid2209.151164","volume":"22","author":"YM Arabi","year":"2016","unstructured":"Arabi YM, Hajeer AH, Luke T, et al. Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia. Emerg Infect Dis. 2016;22(9):1554\u201361. doi:\n                    10.3201\/eid2209.151164\n                    \n                  .","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"760_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12871-016-0198-x","volume":"16","author":"YM Arabi","year":"2016","unstructured":"Arabi YM, Al-Enezi F, Longuere KS, Balkhy HH, Al-Sultan M, Al-Omari A, Al-Hameed FM, Carson G, Shindo N, Fowler R. Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians. BMC Anesthesiol. 2016;16(1):36. doi:\n                    10.1186\/s12871-016-0198-x\n                    \n                  .","journal-title":"BMC Anesthesiol"},{"key":"760_CR42","doi-asserted-by":"publisher","unstructured":"Senga M, Arabi YM, Fowler RA. Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV). J Infect Public Health. 2016. Epub ahead of print. doi:\n                    10.1016\/j.jiph.2016.04.008\n                    \n                  .","DOI":"10.1016\/j.jiph.2016.04.008"},{"issue":"3","key":"760_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jiph.2016.03.004","volume":"9","author":"YM Arabi","year":"2016","unstructured":"Arabi YM, Balkhy HH, Hayden FG, Hui DS, Van Kerkhove MD, Fowler RA. The search for therapeutic options for Middle East Respiratory Syndrome (MERS). J Infect Public Health. 2016;9(3):21\u20135. doi:\n                    10.1016\/j.jiph.2016.03.004\n                    \n                  .","journal-title":"J Infect Public Health"},{"issue":"6","key":"760_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","volume":"160","author":"YM Arabi","year":"2014","unstructured":"Arabi YM, Arifi AA, Balkhy HH, Najm H, Aldawood AS, Ghabashi A, Hawa H, Alothman A, Khaldi A, Al RB. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160(6):389\u201397. doi:\n                    10.7326\/m13-2486\n                    \n                  .","journal-title":"Ann Intern Med"},{"issue":"9","key":"760_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162199","volume":"11","author":"J Dunning","year":"2016","unstructured":"Dunning J, Kennedy SB, Antierens A, et al. Experimental treatment of Ebola virus disease with brincidofovir. PLoS One. 2016;11(9), e0162199. doi:\n                    10.1371\/journal.pone.0162199\n                    \n                  .","journal-title":"PLoS One"},{"issue":"4","key":"760_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001997","volume":"13","author":"J Dunning","year":"2016","unstructured":"Dunning J, Sahr F, Rojek A, et al. Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial. PLoS Med. 2016;13(4), e1001997. doi:\n                    10.1371\/journal.pmed.1001997\n                    \n                  .","journal-title":"PLoS Med"},{"issue":"1","key":"760_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1511812","volume":"374","author":"J Griensven van","year":"2016","unstructured":"van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. New Engl J Med. 2016;374(1):33\u201342. doi:\n                    10.1056\/NEJMoa1511812\n                    \n                  .","journal-title":"New Engl J Med"},{"issue":"12","key":"760_CR48","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S1473-3099(14)70821-7","volume":"14","author":"J Dunning","year":"2014","unstructured":"Dunning J, Baillie JK, Cao B, Hayden FG. Antiviral combinations for severe influenza. Lancet Infect Dis. 2014;14(12):1259\u201370. doi:\n                    10.1016\/s1473-3099(14)70821-7\n                    \n                  .","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0760-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0760-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T12:45:42Z","timestamp":1583153142000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0760-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0760-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"7 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"212"}}